Health Insurance Innovations (HIIQ) PT Raised to $50 at Lake Street Capital Markets; Executing

Health Insurance Innovations (HIIQ) PT Raised to $55 at Canaccord Genuity

Canaccord Genuity raised its price target on Health Insurance Innovations (NASDAQ: HIIQ) to $55.00 (from $39.00) while maintaining a Buy rating.

Health Insurance Innovations (HIIQ) PT Raised to $45 at Craig-Hallum; 'More to Come'

Craig-Hallum raised its price target on Health Insurance Innovations (NASDAQ: HIIQ) to $45.00 while maintaining a Buy rating.

Analyst George Sutton said results were great and the outlook positive with more to come.

Pre-Open Movers 03/01: (NVAX) (DDD) (HIIQ) Higher; (PTLA) (PDCO) (BOX) Lower (more...)

Today's Pre-Open Movers

Novavax, Inc., (Nasdaq: NVAX) 29.9% HIGHER; announced positive top-line results from its Phase 1/2 clinical trial in older adults of its NanoFlu recombinant influenza vaccine, which includes its proprietary Matrix-M adjuvant, compared to the leading licensed egg-based, high-dose influenza vaccine for older adults (IIV3-HD).

Portola Pharma (NASDAQ: PTLA) 23.2% LOWER; reported Q4 EPS of ($1.41), $0.05 better than the analyst estimate of ($1.46). Collaboration and License revenue for the quarter came in at $9.8 million versus the consensus estimate of $6.2... More

Health Insurance Innovations (HIIQ) PT Raised to $60 at Cantor Fitzgerald, 'Fundamentals Accelerating'

Cantor Fitzgerald raised its price target on Health Insurance Innovations (NASDAQ: HIIQ) to $60.00 (from $38.00) while maintaining a Overweight rating.

Analyst Steven Halper comments "We expect HIIQ to continue to benefit from solid demand for its alternative individual health insurance products. We... More

Raymond James Upgrades Health Insurance Innovations (HIIQ) to Outperform

Raymond James upgraded Health Insurance Innovations (NASDAQ: HIIQ) from Market Perform to Outperform.

For an analyst ratings summary and ratings history on Health Insurance Innovations click here. For more ratings news on Health Insurance Innovations click here.

Shares of Health Insurance Innovations closed at $31.20 yesterday.

After-Hours Stock Movers 02/28: (NVAX) (DDD) (QEP) Higher; (PTLA) (BOX) (MNST) Lower (more...)

Today's After-Hours Movers

Novavax, Inc., (Nasdaq: NVAX) 24% HIGHER; announced positive top-line results from its Phase 1/2 clinical trial in older adults of its NanoFlu recombinant influenza vaccine, which includes its proprietary Matrix-M adjuvant, compared to the leading licensed egg-based, high-dose influenza vaccine for older adults (IIV3-HD).

Portola Pharma (NASDAQ: PTLA) 23.2% LOWER; reported Q4 EPS of ($1.41), $0.05 better than the analyst estimate of ($1.46). Collaboration and License revenue for the quarter came in at $9.8 million versus the consensus estimate of $6.2 million. Provides... More

Health Insurance Innovations (HIIQ) Tops Q4 EPS by 3c

Health Insurance Innovations (NASDAQ: HIIQ) reported Q4 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $69.5 million versus the consensus estimate of $59.61 million.

GUIDANCE:

Health Insurance Innovations sees Q1 2018 EPS of $2.45-$2.55. Health Insurance... More